Calorie restriction has been reported to have anti-ageing effects and to play an important role in several neurological diseases. [1] [2] [3] [4] Recently, dietary restriction has received much attention in psychiatry due to its antidepressant and anxiolytic effects. 5, 6 Our previous studies revealed that acute fasting for 9 hours, but not 3 hours or 18 hours, produces antidepressant-like effects in the forced swimming test (FST). We also found that 9 hours of fasting combined with imipramine (30 mg/kg, ip) treatment produced additive antidepressant-like effects in the FST and increased the p-CREB/CREB ratio. 7 However, the mechanisms of the antidepressant-like effects of acute fasting remain unclear.
example reduced estrogen levels in menopause. 9 Several studies have reported that estrogen replacement therapy exerts antidepressive actions in females with depression in clinical studies, as well as females in animal models. 8, 11 Furthermore, estrogen can be combined with selective serotonin re-uptake inhibitors (SSRIs), to produce additive antidepressant-like effects. 12, 13 Curiously, fasting produces estrogenic effects even in ovariectomized mice, 14 and caloric restriction increases expression of estrogen receptors (ERs) but not the expression of the androgen receptors in mouse ovaries. 15 Therefore, this study investigated the antidepressant-like effects of acute fasting combined with estrogen treatment, and the potential mechanisms that might underlie these combined antidepressant effects.
| MATERIAL S AND ME THODS

| Animals
ICR (strain of albino mice originating in Switzerland, mice of this strain have been sent to various places from the Institute of Cancer
Research in the USA, the strain was named ICR after the initial letters of the institute) female mice (8-12 weeks) were obtained from
Jilin University (Changchun, China). Mice were individually housed in plastic cages (25.5 × 15 × 14 cm), with food and water available ad libitum. The mice were maintained in standard laboratory conditions: 23 ± 1°C and 12 hours light/dark cycle (lights on/off at 7:00 am/ 7:00 pm). All behavioural studies were conducted during the light phase. All experiments were conducted in accordance with the Chinese Council on Animal Care Guidelines. 
| Drugs
| Open field test
For the open field test, mice were tested following our previous report 16 after 9 hours fasting. Mice were individually placed in a round acrylic apparatus (48.8 cm in diameter × 16 cm height wall) with a grey floor divided into 19 equal squares. The mice were placed in the centre of the apparatus for 6 minutes and recorded by an overhead digital camera. Horizontal locomotor activity (grid lines crossed with all four paws) and vertical locomotor activity (rearing) were determined by an observer that was blind to the treatment conditions.
The apparatus was cleaned with 70% alcohol before each successive test. Results are expressed as mean ± SEM.
| Forced swimming test
The forced swim test was performed after open field test in the same manner as our previous report. 16 The mice were placed individually into a cylindrical container (height: 25 cm, diameter: 11 cm) filled with water (25°C ± 1°C) to the height of 20 cm. The test was recorded by video camera for 6 minutes. After swimming, mice were removed from the glass cylinder and dried with a towel and kept warm before returning them to their home cages. Behavioural observations were made of the immobility time during the last 4 minutes (240 seconds) of the 6 minutes testing period (mean ± SEM) by observers that were blind to the treatment conditions.
| Protein analysis
| Sample collection
The animals were killed by decapitation immediately after behavioural testing. The PFC and HP were dissected and homogenized in lysis buffer (promega). The homogenates were centrifuged at 10,000 rpm, 4°C for 20 minutes. The supernatant was collected and stored at −80°C until use.
| SDS-PAGE and Western blot analysis
The samples were separated on 10% SDS-PAGE gels. The membranes were incubated with 5% non-fat milk in TBST at room temperature utes. The membranes were visualized by the ECL reagents after exposing the membranes to X-ray film in a dark room. Western blots were scanned and quantified by densitometry, using Image J software.
| Serum corticosterone, ghrelin and estradiol analysis
Serum concentrations of CORT, ghrelin and E2 were quantified using a commercial enzyme-linked immunosorbent assay (ELISA: Jiancheng Bioengineering, Nanjing, China) kit. Forty microlitres of samples were added to pre-coated wells, followed by 10 μL of antibody and 50 μL streptavidin-HRP, and incubated for 1 hour at 37°C. After the last wash, 50 μL of substrate A and 50 μL of substrate B were added to each well and mixed with gentle shaking for 10 minutes at 37°C without light.
Fifty microlitres of stop solution was added to stop the reaction, and the optical density of the wells was measured at 450 nm. The concentrations were determined from the regression line for a standard curve. 17 For all analysis, the enrichment threshold was P < 0.05.
| Immunofluorescence histochemistry
| Statistical analysis
All values are presented as the mean ± SEM Statistical analysis was performed using two-way ANOVA with Factor 1 diet (fasting vs.
non-fasting) and Factor 2 treatment (veh vs E2) or one-way ANOVA followed by Tukey's post hoc tests. Bioinformatics analysis was performed using Student's t test. P values less than 0.05 were considered significant. 
| RE SULTS
| Effects of acute fasting, E2 and TMX in the forced swimming test and open field test
comparisons between groups showed that immobility time was significantly reduced by 9 hours of fasting compared with the non-fasting/VEH group (P < 0.001). Administration of E2 (15 µg/kg) reduced the immobility time in both non-fasting and fasting mice (P < 0.001, non-fasting; P < 0.05, fasting), although to a lesser degree in fasting mice which accounted for the significant interaction. Figure 1D shows similar additive antidepressant-like effects of estrogen in fasting mice that was reversed by administration of TMX (F (3, 20) = 14.46, P < 0.001; post hoc P < 0.001). TMX also reversed the effect of fasting alone on immobility time in the forced swim test (P < 0.05). In both cases, TMX treatment brought immobility scores back to the level of control mice (about 200 seconds; Figure 1A ).
These effects seemed to be behaviourally selective. Neither fasting nor E2 had any significant effect on the number of line crosses.
| Effects of fasting, E2 and TMX on total CREB and p-CREB protein levels in the PFC and HP
Western blotting results for CREB and p-CREB in PFC are shown in Figure 2A in Figure 2B ) . Post hoc comparisons between groups showed p-CREB levels in PFC were significantly increased by either E2 or 9 hours fasting compared with the non-fasting control group (P < 0.05 for E2; P < 0.05 for 9 hours fasting in Figure 2B ). As shown in Figure 2E ,F, increasing effects of the CREB and p-CREB levels with E2 in fasting mice were reversed by administration of TMX (CREB:F (3, 20) = 7.628, P < 0.01; post hoc P < 0.01; pCREB:F (3, 20) = 3.557, P < 0.05; post hoc P < 0.05), bringing the values down to those of untreated mice (eg vehicle/non-fasting in Figure 2A ,B). A significant decrease in total CREB levels in PFC was observed from TMX alone in fasting mice (P < 0.05).
Two-way ANOVA also indicated that E2 treatment and Figure 2D ). Post hoc analysis showed that administration of E2 significantly increased the levels of CREB and p-CREB in non-fasting mice (P < 0.05 in Figure 2C ; P < 0.01 in Figure 2D ).
Fasting also increased p-CREB levels compared with non-fasting mice (P < 0.001 in Figure 2D ). One-way ANOVA showed that effects of E2 with fasting on CREB and p-CREB levels were reversed by TMX (CREB:F (3, 20) = 5.321, P < 0.05; post hoc P < 0.05 in Figure 2G ; p-CREB: F (3, 20) = 8.532, P < 0.001; post hoc P < 0.001 in Figure 2H ), again returning the values to control levels.
| Effects of fasting, E2 and TMX on BDNF protein levels in the brain
As shown in Figure 2I ,J, both E2 treatment and 9 hours fasting Figure 2J ). Post hoc comparisons between groups showed that the 9 hours fasting significantly increased levels of BDNF compared with the non-fasting/VEH group both in the PFC (P < 0.01) and the HP (P < 0.001). E2 treatment also significantly increased levels of BDNF compared with non-fasting/VEH group both in the PFC and the HP (P < 0.01 in the PFC, and P < 0.01 in the HP). Effects of E2 with fasting on BDNF levels in both the PFC and HP were reversed by TMX, as shown in Figure 2K (one way ANOVA, F (3, 20) = 3.257, P < 0.05) and Figure 2L (one way ANOVA, F (3, 20) = 9.087, P < 0.001). Post hoc comparisons between groups showed that TMX administration inhibited the combined effects of E2 and fasting in the PFC (P < 0.05) and HP (P < 0.001), returning levels to baseline. However, although TMX also slightly reduced BDNF levels that were elevated by fasting alone, no significant differences were observed.
| Effects of acute fasting, E2 and TMX on cell proliferation in the SGZ of the hippocampal dentate gyrus
As shown in Figure 3 , 9 hours fasting increased the number of BrdUpositive cells in the SGZ of the hippocampal dentate gyrus. In addition, E2 treatment produced additive effects with fasting in the increase in BrdU expression. This effect was antagonized by TMX.
F I G U R E 1 Effects of acute 9 h fasting, E2 and TMX on immobility time in the FST and locomotor activity in the OPT. FST: A and D; OFT: B, C, E and F. N = 6 per group. Data represented as mean ± SEM were analysed by two-way (diet × treatment) ANOVA followed by post hoc comparisons for the data presented in A, B and C, or by one-way ANOVA followed by post hoc analysis for the data presented in D, E and F. *** P < 0.001 compared with the non-fasting + vehicle group; & P < 0.05 compared with the fasting + vehicle group; ### P < 0.001 compared with the E2 + fasting group. VEH: vehicle; E2: 17 β-estradiol; TMX: tamoxifen
| Effects of acute fasting, E2 and TMX on serum ghrelin, E2 and CORT levels
A one-way ANOVA revealed a significant difference in ghrelin ( Figure 4A , F (4, 20) = 3.572, P < 0.05), E2( Figure 4B , F (4, 15) = 3.783, P < 0.05) and CORT ( Figure 4C , F (4, 25) = 4.364, P < 0.01) levels between groups. Although fasting alone did not produce a significant increase in ghrelin, post hoc comparisons revealed that fasting combined with estrogen did increase the level of ghrelin compared with the non-fasting group (P < 0.01). These effects of E2 in fasting mice were partially reversed by TMX administration (P < 0.05). Figure 4B shows that after 9 hours fasting, the level of E2 was enhanced significantly (P < 0.05), and E2 produced additive effects with fasting, increasing E2 levels. However, there were no substantial difference after TMX treatment. Figure 4C shows that after the E2 treatment in fasting mice, the CORT level was significantly reduced compared with non-fasting/VEH group (P < 0.05) and fasting/VEH group (P < 0.05) and these effects were inhibited by TMX administration (P < 0.05).
F I G U R E 2 Effects of acute 9 h fasting, E2, and TMX on the CREB/BDNF signalling pathway in the PFC and HP. N = 6 per group. A, E: CREB/ β-actin in PFC. B, F: p-CREB/ β-actin in PFC. C, G: CREB/ β-actin in HP. D, H: p-CREB/ β-actin in HP. I, K: BDNF/ β-actin in PFC. J, L: BDNF/ β-actin in HP. Data represented as mean ± SEM were analysed by two-way (diet × treatment) ANOVA followed by pairwise comparisons for the data presented in A-D and I, J or one-way ANOVA followed by post hoc analysis for the data presented in in E-H and K, L. * P < 0.05; ** P < 0.01; *** P < 0.001 compared with the non-fasting + vehicle group; & P < 0.05, && P < 0.01 compared with the fasting + vehicle group. # P < 0.05; ## P < 0.01; ### P < 0.001 compared with the E2 + fasting group. VEH: vehicle; E2: 17 β-estradiol; TMX: tamoxifen.
| Identification of differential gene expression in the PFC and HP in mice after fasting or E2 treatment
Venn diagrams in Figure 5A ,B showed that there was a considerable overlap in genes regulated by fasting and E2 treatment compared to the non-fasting/VEH group in the PFC and HP. In the PFC, in the fasting/VEH group, 383 transcripts were up-regulated, and 246 transcripts were down-regulated when compared to the non-fasting/VEH group. In the non-fasting E2 group, 369
transcripts were found to be up-regulated and 218 transcripts were down-regulated when compared to the non-fasting/VEH group. Interestingly, the two treatments had 212 genes that were similarly up-regulated and 76 genes that were down-regulated in common. In the HP, in the fasting/VEH group, 156 transcripts were up-regulated, and 328 transcripts were down-regulated when compared the non-fasting/VEH group. In the non-fasting E2 group, 124 transcripts were found to be up-regulated and 389 transcripts were down-regulated when compared to the nonfasting/VEH group. Interestingly, the proportion of co-regulated genes was smaller, with the two different treatments having 13 genes that were similarly up-regulated and 25 genes that were down-regulated.
| Gene Ontology (GO) enrichment in the PFC and HP in mice after fasting or E2 treatment
Fasting produced effects that were enriched for genes involved in neurogenesis ( Figure 5C : P < 0.001 in fasting/VEH vs non-fasting/ VEH groups), central nervous system development and cerebral cortex neuron differentiation. E2 treatment in VEH mice produced effects that were enriched for genes involved in central cortex neuron differentiation, dopaminergic synaptic transmission and GABAergic neuron differentiation ( Figure 5C : P < 0.001 in non-fasting/E2 vs non-fasting/VEH groups). Significant enrichment was produced by fasting and E2 for all these functions in PFC, even though some were more affected by one treatment or the other. Figure 5D shows the gene ontology analysis in the HP for fasting and E2 treatments.
Again, there were substantial overlaps between these effects even though one or the other treatment had greater effects on particular gene sets. Fasting had more effect on GABAergic synaptic transmission and neuron-neuron synaptic transmission (P < 0.01 in fasting/ VEH vs non-fasting/VEH groups). Neuron-neuron synaptic transmission was also the gene class most affected by E2 in VEH mice Figure 5E shows examples of genes that are regulated in common in fasting/VEH and non-fasting/E2 mice in the PFC and HP from these gene categories identified in GO analyses. Down-regulated genes included Drd1, Drd2, Pde1b, Cartpt, Adora2a and Rasd2 in the PFC. Up-regulated genes in the PFC included Dlx1, Eomes, Fabp7
and Pkd1, while Cplx3 and Chrnb4 were up-regulated in HP.
| D ISCUSS I ON
Our previous studies demonstrated that acute 9 hours fasting has antidepressant-like effects in male mice. 7 In this study, we find that fasting reduced immobility time in female mice, and that E2
produces an additive effect on immobility time without changing locomotor activity. These antidepressant-like effects were blocked by TMX, which is a mixed estrogen receptor antagonist. 18 This suggests that the estrogen receptor is involved in antidepressant-like effects of fasting as well as E2.
To further investigate the mechanisms of the antidepressant-like effects of fasting and E2, Western blotting examined the CREB-BDNF pathway, which has repeatedly been associated with the effects of pharmacological treatments that produce antidepressantlike behavioural changes. Nine hours fasting, as well as E2 treatment, enhanced total CREB and p-CREB levels in both PFC and HP. These effects were blocked by TMX, suggesting that both effects involved estrogen receptors. These findings support previous findings that E2
increases CREB protein expression, as well as p-CREB expression in the HP. 19 Similarly, these results are consistent with another study that reported p-CREB was increased in chronic caloric restricted mice. 20 Downstream from these changes in p-CREB and CREB expression, BDNF protein levels were also increased after 9 hours fasting in the PFC and HP, and E2 produced comparable effects.
TMX treatment reversed these effects, again implicating estrogen receptors in both the effects of fasting and E2. Estrogen has been suggested to be one of factors influencing levels of BDNF mRNA and protein expression 21 and calorie restriction up-regulates BDNF/ TrkB expression in the HP of dietary-induced obese rats. 22 Based on the current CREB-BDNF signalling results, we have been suggested that the CREB-BDNF pathway is at least partly involved in the antidepressant-like effects of acute fasting and E2 found here.
Moreover, increased BDNF expression by antidepressants is thought to influence another fundamental mechanism of these effects: neurogenesis, 23 which also appears to play a role in the antidepressant-like effects of fasting and E2. BrdU-positive cells were increased by 9 hours fasting, and the addition of E2 further increased the number of BrdU-positive cells compared with the non-fasting group or the fasting alone group. Moreover, this effect was also blocked by TMX, implicating a role of E2 in these changes as well. It has been reported that estrogen deficiency reduces adult hippocampal neurogenesis, 24 and depression is of course linked to a variety of conditions that involve reduced or altered estrogen function, including post-partum depression 25 and menopause. 26 Dietary restriction is also known to alter the process of neurogenesis. 27 Taken together, these data suggest that neurogenesis may be involved in estrogenmediated antidepressant-like effects of acute fasting in female mice.
To further elucidate the mechanisms of the antidepressant-like effects of fasting and E2, we examined serum ghrelin, estrogen and CORT levels. CORT levels did not appear to be significantly affected by 9 hours fasting treatment. CORT is one of the effector hormones of the hypothalamic-pituitary-adrenal (HPA) axis and is mildly increased by a longer period of fasting. 28 In any case, with respect to the present results, it does not appear that CORT contributes to the antidepressant-like effects of fasting. By contrast, ghrelin levels were significantly changed by fasting or fasting plus E2. It has been reported that fasting increases ghrelin levels 29 and ghrelin treatment significantly increases estradiol secretion. 30 Thus, ghrelin secretion may account for the apparent estrogen mediation of the effects of fasting. This hypothesis is supported by the ability of TMX to antagonize the effects of fasting. Moreover, increases in estradiol secretion do not occur in GHSR 1a knockout (Ghsr1a-/-) mice after calorie restriction, 6 which is a further indication of this ghrelin-estrogen connection. These results suggest that ghrelin may be related to the antidepressant-like effects of calorie restriction, but the direction of these effects is open to some question. After the addition of E2, ghrelin levels were higher than in the non-fasting control group and TMX blocked the enhancement of ghrelin level compared with fasting plus E2. Indeed, effects of estrogen on ghrelin levels have been reported by previous studies. 31 Estrogen treatment significantly increased the level of ghrelin production and ghrelin mRNA expression, and ICI-182 780 (a pure ER antagonist) completely reversed the effect of estrogen. 31 E2 levels were also changed by fasting or fasting plus estrogen. These effects were also blocked by TMX. Thus, it appears that ghrelin and E2 play roles in the antidepressant-like effects of fasting and E2, but the exact nature of this interaction remains to be fully elucidated and may be bidirectional.
Besides cellular and molecular mechanisms of fasting and estrogen, genomic mechanisms were also examined here. RNA-seq has been used to explore differences in gene expression in depression. 32 Transcriptome analysis was performed in calorie-restricted rats to explore the mechanisms of calorie restriction on neuroprotection and its positive effects on ageing-related declines in neural function. 33 Here, fasting and E2 treatments were found to have substantial overlaps in their effects on gene expression, particularly in the PFC, where 212 genes were up-regulated and 76 genes were downregulated in common. In the HP, fasting and E2 treatments had less overlap, with 13 genes dually up-regulated and 25 genes dually down-regulated. The PFC thus contains more co-expressed DEGs than HP. In addition, the GO analysis found that there were many neurological functions enriched in DEGs after fasting or E2 treatment in both PFC and HP. More affected genes were related to neural and synaptic function, including neurogenesis, central nervous system development, forebrain neuron differentiation and synaptic transmission, especially GABAergic and dopaminergic transmission.
It is well known that neuroprotection and changes in synaptic transmission are associated with antidepressant-like effects. 34 In PFC, fasting or E2 co-treatment down-regulated phosphodiesterase-1b (Pde1b). PDE1 is a dual substrate for cAMP and cGMP and is found in areas rich in dopamine (DA). It has been reported that Pde1b knockout mice are resistant to forced swim and tail suspension induced immobility. 35 Fasting or E2 treatment also down-regulated the adenosine A2a receptor (Adora2a). ADORA2A in the amygdala has a role in anxiety. 36 RASD Family Member 2 (Rasd2), also down-regulated in the PFC of fasting or E2 treated mice, is also affected by chronic stress in the PFC of mice. 37 Complexin 3 (Cplx3) was induced in HP by both fasting and estrogen. It has been reported that antidepressants increase Cplx3 in rat HP. 38 Taken together, we found that fasting and E2 have substantially co-regulated gene expression in the PFC and HP, affecting similar neural functions, and in a manner consistent with other antidepressant treatments. Co-regulated gene expression and their effects on neural function in these brain regions may be related to another mechanism of the additive antidepressant-like effects of fasting and E2.
Estradiol replacement therapy is an effective treatment of depression for perimenopausal women, 39 as well as some other conditions that involve impaired estrogen function. The current results would suggest that fasting may be an adjunctive treatment to hormone replacement therapy for postmenopausal women with depressive symptoms, or other conditions in which estrogen function is disrupted, resulting in depressive symptomatology.
| CON CLUS ION
In conclusion, our data show that acute fasting produces antidepressant-like effects in female mice and E2 produces additive antidepressant-like effects when combined with fasting. The additional effectiveness of E2 may be related to neuroplasticity by increasing of the CREB-BDNF and neurogenesis. Moreover, serum ghrelin and estrogen are also increased by fasting and E2 and may be important mediators of these effects. Moreover, the results of RNAseq analysis suggest that fasting and E2 co-regulate similar gene targets that affect neural and synaptic functions in the PFC and HP. In summary, we conclude that E2 produces additive antidepressant-like effects with fasting, and that fasting might be used as an adjunct to estrogen replacement therapy. 
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